Industries

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.

These disruptions continue t...

The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions.

Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys...

The cosmetic and aesthetic procedures market is undergoing a significant transformation, driven by a shift away from invasive surgical interventions toward minimally invasive and non-invasive treatments. Traditional cosmetic surgeries are often associated with higher procedural risks, longer recovery times, and increased costs, whereas emerging tec...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...

The rise of centennial humans highlights a structural shift in demographics, economies, and care, driven by longer life expectancy and advances in healthcare. The global population is aging rapidly, with centenarians increasing at a faster rate, especially in aging societies such as Japan and parts of Europe, and gradually in countries such as Indi...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point whe.....

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, neuromodulation systems, and diagnostic solutions industry.

The issue features advanced medical devices such as intelligent drug delivery system, immersive th...

This study focuses on the global electrophysiology (EP) ablation devices market. It analyzes the market for catheter-based ablation technologies used primarily to treat cardiac arrhythmias (especially atrial fibrillation), including radiofrequency (RF), cryoablation, pulse field ablation (PFA), and emerging modalities.

The global EP ablation...